The DCB Open Innovation Challenge 2025 is proceeding to the next round! We are very happy to announce the Top 5...

DCB Open Innovation Challenge 2025: Meet our Top 5!
DCB Open Innovation Challenge 2025: Meet our Top 5!
The DCB Open Innovation Challenge 2025 is proceeding to the next round! We are very happy to announce the Top 5 who rocked the stage at our Pitch Day and impressed our esteemed jury with their ideas.

Meet our Top 5!
After a thorough review of 54 remarkable submissions for our Open Innovation Challenge, 15 promising teams were invited to present their ideas live at our Pitch Day.
Following an exciting day of pitches and innovation, we are thrilled to announce the 5 finalists who impressed the jury and secured their place in this year’s exclusive bootcamp and a chance to shine at our awards event.
We encourage you to discover the full profiles of our top 5 innovators in the attached PDF or down below!
Join us in celebrating their incredible journey, and secure your ticket for the Day of Innovation to witness the finale in person: https://lnkd.in/dH-8n3v5
Downloads

Alva Innovations Inc. (US) - In-line, just-in-time insulin fibril filtration — NO skin irritation!
Alva Innovations has developed a just-in-time filtration platform that removes insulin fibrils during pump therapy, thereby prolonging the lifespan of pump sets and maintaining healthy skin.

Neuraura (CAN) - LoOoP by Neuraura: proactive management of diabetes risk in PCOS population (polycystic ovary syndrome)
LoOoP by Neuraura is a first in-kind solution for PCOS (polycystic ovary syndrome), combining a biowearable with a digital platform. 70% of individuals with PCOS develop insulin resistance and 50% develop pre-/diabetes before 40.

YW MEMS (CHN) - Insulin patch pump drive
The MEMS MicroPump Module offers a highly integrated, precise, accurate and secure technology for insulin infusion, empowering the miniaturization and intelligent precision control for insulin pump.

SynchNeuro (USA) - Brain signal-based non-invasive glucose monitor
SynchNeuro offers a discreet, brain-signal-based wearable and app for continuous glucose and cardiometabolic monitoring, targeting prediabetic and type 2 diabetes adults for $10/month.

Diawiser (LTU) - Diawiser
Diawiser is a non-invasive software that detects blood glucose abnormalities with voice.
More recent news
DCB Open Innovation Challenge 2025: Meet our Top 5!
DCB Open Innovation Challenge 2025: Meet our Top 15!
The DCB Open Innovation Challenge 2025 is proceeding to the next round! We are very happy to announce the Top 15 that...
Diabetes Center Berne @ BEA
DCB joined the Focus Day at BEA in Bern, an event highlighting the latest in healthcare innovation. It was a great...


DCB Research AG
Freiburgstrasse 3
3010 Bern
Switzerland
